DrugPatentWatch Database Preview
Details for Patent: 8,231,885
» See Plans and Pricing
Which drugs does patent 8,231,885 protect, and when does it expire?
Patent 8,231,885 protects MIRVASO and is included in one NDA.
This patent has eighty patent family members in twenty-four countries.
Summary for Patent: 8,231,885
| Title: | Compounds, formulations, and methods for ameliorating telangiectasis |
| Abstract: | Methods, compounds, and topical formulations for treatment of telangiectasias are disclosed. The methods comprise topically applying a composition comprising an .alpha.-adrenergic receptor agonist to telangiectatic skin. Amelioration of telangiectasia symptoms begins within minutes after topical application of a disclosed composition. A single application can significantly lessen telangiectasia discoloration for at least about 2 hours. |
| Inventor(s): | DeJovin; Jack A. (New Brunswick, NJ), DeJovin; Isabelle Jean (New Brunswick, NJ) |
| Assignee: | Galderma Laboratories Inc. (Fort Worth, TX) |
| Application Number: | 12/544,663 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 8,231,885 |
|
Patent Claim Types: see list of patent claims | Composition; Delivery; Formulation; |
Drugs Protected by US Patent 8,231,885
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Galderma Labs Lp | MIRVASO | brimonidine tartrate | GEL;TOPICAL | 204708-001 | Aug 23, 2013 | RX | Yes | Yes | Start Trial | Start Trial | Y | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 8,231,885
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Austria | 530185 | Start Trial | |||
| Australia | 2004242967 | Start Trial | |||
| Australia | 2005247467 | Start Trial | |||
| Australia | 2011231543 | Start Trial | |||
| Brazil | 112012024289 | Start Trial | |||
| Brazil | PI0511519 | Start Trial | |||
| Canada | 2530938 | Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
